It is noteworthy that many of these studies evaluated p53 expression in patients with cancer whereby normal status of p53 was assessed using tissues from the age-matched groups or the normal adjacent sites that are otherwise defined to be normal by histological means (Ren et al., 1996; Pontén et al., 1997; Cruz et al., 2002). This evidence concerns the gene TP53 and cancer.